Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol

Infant acute lymphoblastic leukemia (ALL) is characterized by a high incidence of KMT2A gene rearrangements and poor outcome. We evaluated the value of minimal residual disease (MRD) in infants with KMT2A-rearranged ALL treated within the Interfant-06 protocol, which compared lymphoid-style consolid...

Descripción completa

Detalles Bibliográficos
Autores principales: Stutterheim, Janine, van der Sluis, Inge M., de Lorenzo, Paola, Alten, Julia, Ancliffe, Philip, Attarbaschi, Andishe, Brethon, Benoit, Biondi, Andrea, Campbell, Myriam, Cazzaniga, Giovanni, Escherich, Gabriele, Ferster, Alina, Kotecha, Rishi S., Lausen, Birgitte, Li, Chi Kong, Lo Nigro, Luca, Locatelli, Franco, Marschalek, Rolf, Meyer, Claus, Schrappe, Martin, Stary, Jan, Vora, Ajay, Zuna, Jan, van der Velden, Vincent H. J., Szczepanski, Tomasz, Valsecchi, Maria Grazia, Pieters, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196086/
https://www.ncbi.nlm.nih.gov/pubmed/33405950
http://dx.doi.org/10.1200/JCO.20.02333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196086/
https://www.ncbi.nlm.nih.gov/pubmed/33405950
http://dx.doi.org/10.1200/JCO.20.02333

Ejemplares similares